Diallo Modibo

Dr. Diallo Modibo

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DMDiallo Modibo
Diallo Modibo
CCCécile Courdier
Cécile Courdier
EMElina Mercier
Elina Mercier
ASAngèle Sequeira
Angèle Sequeira
ADAlicia Defay-Stinat
Alicia Defay-Stinat
BABenoit Arveiler
Benoit Arveiler
Albinism is a genetically heterogeneous disease in which 21 genes are known so far. Its inheritance mode is autosomal recessive except for one X-linked form. The molecular analysis of exonic sequences of these genes allows for about a 70% diagnostic rate. About half (15%) of the unsolved cases are heterozygous for one pathogenic or probably pathogenic variant. Assuming that the missing variant may be located in non-coding regions, we performed sequencing for 122 such heterozygous patients of either the whole genome (27 patients) or our NGS panel (95 patients) that includes, in addition to all exons of the 21 genes, the introns and flanking sequences of five genes, TYR, OCA2, SLC45A2, GPR143 and HPS1. Rare variants (MAF < 0.01) in trans to the first variant were tested by RT-PCR and/or minigene assay. Of the 14 variants tested, nine caused either exon skipping or the inclusion of a pseudoexon, allowing for the diagnosis of 11 patients. This represents 9.8% (12/122) supplementary diagnosis for formerly unsolved patients and 75% (12/16) of those in whom the candidate variant was in trans to the first variant. Of note, one missense variant was demonstrated to cause skipping of the exon in which it is located, thus shedding new light on its pathogenic mechanism. Searching for non-coding variants and testing them for an effect on RNA splicing is warranted in order to increase the diagnostic rate.

9 May 2024 in Pigment Cell & Melanoma Research
Verified
Journal Article
Open access
DMDiallo Modibo
Diallo Modibo
OSOusmane Sylla
Ousmane Sylla
MSMohamed Kole Sidibé
Mohamed Kole Sidibé
CPClaudio PLAISANT
Claudio PLAISANT
EMElina Mercier
Elina Mercier
BABenoit Arveiler
Benoit Arveiler
Albinism is a phenotypically and genetically heterogeneous condition characterized by a variable degree of hypopigmentation and by ocular features leading to reduced visual acuity. Whereas numerous genotypic studies have been conducted throughout the world, very little is known about the genotypic spectrum of albinism in Africa and especially in sub‐Saharan Western Africa. Here we report the analysis of all known albinism genes in a series a 23 patients originating from Mali. Four were diagnosed with OCA 1 (oculocutaneous albinism type 1), 17 with OCA 2, and two with OCA 4. OCA2 variant NM_000275.3:c.819_822delinsGGTC was most frequently encountered. Four novel variants were identified (two in TYR, two in OCA2). A deep intronic variant was found to alter splicing of the OCA2 RNA by inclusion of a pseudo exon. Of note, the OCA2 exon 7 deletion commonly found in eastern, central, and southern Africa was absent from this series. African patients with OCA 1 and OCA 4 had only been reported twice and once, respectively, in previous publications. This study constitutes the first report of the genotypic spectrum of albinism in a western sub‐Saharan country.

7 March 2024 in medRxiv
Verified
Preprint
Open access
PDF file
DMDiallo Modibo
Diallo Modibo
OSOusmane Sylla
Ousmane Sylla
MSMohamed Kole Sidibé
Mohamed Kole Sidibé
CPClaudio PLAISANT
Claudio PLAISANT
EMElina Mercier
Elina Mercier
BABenoit Arveiler
Benoit Arveiler
Albinism is a phenotypically and genetically heterogeneous condition characterized by a variable degree of hypopigmentation and by ocular features leading to reduced visual acuity. Whereas numerous genotypic studies have been conducted throughout the world, very little is known about the genotypic spectrum of albinism in Africa and especially in Sub-Saharan Western Africa. Here we report the analysis of all 20 known albinism genes in a series a 23 patients originating from Mali. Four were diagnosed with OCA 1 (oculocutaneous albinism type 1), 17 with OCA 2, and 2 with OCA 4. OCA2 variant NM_000275.3:c.819_822delinsGGTC was most frequently encountered. Four novel variants were identified (2 in TYR , 2 in OCA2 ). A deep intronic variant was found to alter splicing of the OCA2 RNA by inclusion of a pseudo exon. Of note, the OCA2 exon 7 deletion commonly found in eastern, central and southern Africa was absent from this series. African patients with OCA 1 and OCA 4 had only been reported twice and once respectively in previous publications. This study constitutes the first report of the genotypic spectrum of albinism in a western Sub-Saharan country.

8 April 2026
Verified
Thesis
Closed access
DMDiallo Modibo
Diallo Modibo
L’albinisme est une condition génétique phénotypiquement et génétiquement hétérogène caractérisée par un degré variable d’hypopigmentation et des atteintes oculaires. Le diagnostic moléculaire de l’albinisme repose sur l’analyse systématique des 21 gènes connus à la recherche de SNV et de CNV. Le rendement diagnostique est d’environ 70%. Cette thèse a pour but d’améliorer le taux de diagnostic. Afin d’atteindre cet objectif, d’une part, nous avons utilisé un panel NGS élargi incluant la totalité des introns des gènes des 5 formes les plus fréquentes d’albinisme, TYR, OCA2, SLC45A2, GPR143 et HPS1, et d’autre part, nous avons réalisé le séquençage de génome entier. Dans une première partie nous avons analysé 23 patients atteints d’albinisme oculocutané originaires du Mali. Le diagnostic a pu être obtenu chez tous les patients. L’OCA2 était la forme la plus fréquente (17/23, 74%), suivi d’OCA1 (4/23, 17%) et OCA4 (2/23, 9%). La délétion-insertion NM_000275.3:c.819_822delinsGGTC d’OCA2 a été le variant prédominant. Quatre nouveaux variants ont été identifiés, dont 2 dans TYR et 2 dans OCA2. L’un des nouveaux variants est un variant intronique profond qui modifie l'épissage de l'ARN d’OCA2 par l'inclusion d'un pseudoexon. Cette étude constitue le premier rapport sur le spectre génotypique de l'albinisme dans un pays subsaharien occidental. La deuxième partie de la thèse a consisté en l’analyse des variants d’épissages chez 121 patients hétérozygotes pour un variant pathogène. Parmi les variants testés (RT-PCR ou minigène), 9 variants ont montré un impact sur l’épissage en provoquant soit un saut d’exon, soit l’inclusion d’un pseudoexon pathogène. Ce travail a permis d’établir le diagnostic chez 11 patients, ce qui représente 9,1 % de diagnostic supplémentaire sur l’ensemble des patients non résolus inclus dans cette étude. Dans la troisième partie nous avons mis en évidence 9 nouveaux variants rares dans les enhancers candidats du gène OCA2 et une grande délétion en amont de TYR, emportant deux enhancers distaux. Ces variants ne peuvent pas encore expliquer la maladie car leur pathogénicité doit être validée d’abord par des tests fonctionnels qui sont en cours d’optimisation. Dans la dernière partie, nous avons effectué l’analyse d’exomes chez 15 patients sans diagnostic. Le diagnostic a pu être redressé chez 2 patients par l’identification de variants pathogènes dans TYR. Un variant d’intérêt a été identifié dans RAB9A, un gène candidat. Cependant, des tests fonctionnels sont nécessaires pour valider ce variant. Dans TPCN2, un possible gène d’albinisme, deux variants intéressants ont été mis en évidence, l’un nécessite des tests fonctionnels et l’autre déjà décrit pathogène a permis d’établir le diagnostic chez le patient.

17 June 2026 in Molecular Genetics and Metabolism Reports
Verified
Journal Article
Open access
DMDiallo Modibo
Diallo Modibo
ADAlicia Defay-Stinat
Alicia Defay-Stinat
CPClaudio PLAISANT
Claudio PLAISANT
SDSabine Derrien
Sabine Derrien
EMElina Mercier
Elina Mercier
BABenoit Arveiler
Benoit Arveiler
Albinism is characterized by generalized hypopigmentation and ocular features resulting from impaired melanin biosynthesis. Most known pathogenic variants are rare (MAF < 0.001) and found in coding regions. The role of non-coding variants, especially those with higher allele frequencies, is generally not investigated. Our next generation sequencing panel that includes the entire sequence of five major albinism genes (TYR, OCA2, SLC45A2, GPR143 and HPS1) identified compound OCA2 heterozygosity in a patient with a rare (MAF:0,0003) coding variant, NM_000275.3:c.1025 A > G;p.(Tyr342Cys) and a more common intronic variant, NM_000275.3:c.574-19 A > G (MAF:0,0087, with 80 homozygotes in the control population GnomADv4.1.0). In silico prediction tools indicated that this intronic variant could alter splicing. RT-PCR analysis on RNA extracted from the patient's blood revealed the skipping of exons 6 and 7, which resulted in the in-frame deletion of 78 amino acids. Protein modelling suggested that this deletion disrupts the GOLD-like domain and leads to the loss of conserved N-glycosylation sites, likely impairing protein folding and intracellular trafficking. These findings provided strong evidence for a deleterious effect on OCA2 function. Therefore, the variant was classified as likely pathogenic, allowing to establish the diagnosis in the patient. The relatively high allele frequency of this variant suggests that it behaves as a hypomorphic allele leading to disease in a compound heterozygous state. This underscores that intronic variants outside the canonical splice sites must be taken in consideration and functionally tested, and that common variants should not be systematically discarded in the diagnosis of albinism, and, similarly, of other rare diseases.